Modern Biosciences

IP Group set up Modern Biosciences in May 2005 as a specialist drug in-licensing and development company. Its objective is to operate as a channel between the life science academic research community within the UK and the pharmaceutical industry.

Modern Biosciences’ business model provides a channel for exciting early stage drug candidates to reach industry and is based around:

• sourcing drug candidates from partner organisations
• funding and managing development programmes to value inflexion
• forming commercial alliances with industry for later stage development and marketing

Modern Biosciences entered into a Memorandum of Understanding with the University of Manchester relating to the commercialisation of drug related intellectual property in March 2006.

It has since entered into an exclusive licence and research agreement with the University of Manchester and the University of Salford for the development of a new class of cancer drug.

Modern Bioscience’s Chief Operating Officer is Dr Alex Stevenson. He has spent the last 10 years working in a variety of scientific and management positions, with a particular focus on drug development and IP commercialisation. For more information, please visit Modern Bioscience’s website at www.modernbiosciences.com.

Top of page